Literature DB >> 512369

Anomalous reactions in the haemagglutination assay for anti-collagen antibodies: studies on patients with rheumatoid arthritis or chronic low back pain.

H K Beard, D J Lea, R Ryvar.   

Abstract

Sera from 23 patients with chronic low back pain, 20 rheumatoid patients and 16 normal controls were tested for antibodies to collagen types I, II and III, both native and denatured, by haemagglutination. Weak reactions against denatured collagen types I and II were found in 30-40% of the sera. Sera from individuals with rheumatoid arthritis or chronic low back pain behaved similarly, while only one normal serum showed any positive reaction. Reactions to denatured collagen type III and to native collagen of all 3 types were largely negative. Non-antibody serum components were thought to be responsible for these haemagglutination reactions since weakly positive reactions were abolished by cryoprecipitation and could not be confirmed by a solid-phase fluorimetric assay. Using the latter technique sera from 62 rheumatoid patients were screened for antibodies to type II collagen (native and denatured) and only one positive serum found. We conclude that haemagglutination is subject to false positive reactions and that the incidence of anticollagen antibodies in sera from patients with rheumatoid arthritis or chronic low back pain is low.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 512369     DOI: 10.1016/0022-1759(79)90292-8

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  14 in total

1.  The immune response of guinea-pigs to type II collagen: poor cross-reactivity with homologous type II collagen accounts for resistance to collagen-induced arthritis.

Authors:  A D Hernandez; M A Cremer; A S Townes; J M Stuart; A H Kang
Journal:  Immunology       Date:  1988-04       Impact factor: 7.397

Review 2.  What do anti-collagen antibodies mean?

Authors:  K Morgan
Journal:  Ann Rheum Dis       Date:  1990-01       Impact factor: 19.103

3.  Collagen of the calcified layer of human articular cartilage.

Authors:  S Roberts
Journal:  Experientia       Date:  1985-09-15

4.  Studies on reticulin. I: Serological and immunohistological investigations of the occurrence of collagen type III, fibronectin and the non-collagenous glycoprotein of Pras and Glynn in reticulin.

Authors:  D J Unsworth; D L Scott; T J Almond; H K Beard; E J Holborow; K W Walton
Journal:  Br J Exp Pathol       Date:  1982-04

5.  Anti-collagen antibodies in sera from rheumatoid arthritis patients.

Authors:  H K Beard; R Ryvar; J Skingle; C L Greenbury
Journal:  J Clin Pathol       Date:  1980-11       Impact factor: 3.411

6.  Adjuvant-induced arthritis in rats. Evidence that autoimmunity to homologous collagens types I, II, IX and XI is not involved in the pathogenesis of arthritis.

Authors:  M A Cremer; A S Townes; A H Kang
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

7.  Pepsinogen--an immunoglobulin binding artefact in 'collagen' preparations.

Authors:  A P Kirk; B P O'Hara; R A Mageed; M S McMahon; D McCarthy; S Menashi; J R Archer; H L Currey
Journal:  Clin Exp Immunol       Date:  1986-09       Impact factor: 4.330

8.  Absence of autoimmunity to type II collagen in generalised nodal osteoarthritis.

Authors:  R B Clague; K Morgan; I Collins; M Pattrick; M Doherty
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

9.  Binding of immunoglobulins and immune complexes to cartilage derived extracts.

Authors:  W R Alomari; J R Archer; R Brocklehurst; H L Currey
Journal:  Clin Exp Immunol       Date:  1983-12       Impact factor: 4.330

10.  Autoantibodies in childhood scleroderma.

Authors:  R M Bernstein; R S Pereira; A J Holden; C M Black; A Howard; B M Ansell
Journal:  Ann Rheum Dis       Date:  1985-08       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.